FDA Dietary Supplement Claims Oversight Will Be “More Aggressive” – Troy
This article was originally published in The Tan Sheet
Executive Summary
FDA plans to intensify enforcement of inappropriate structure/function claims, Chief Counsel Daniel Troy asserted at the Food & Drug Law Institute educational conference April 16-17
You may also be interested in...
CFSAN Adverse Event Strategy: Will Notifying Industry Create A 2-Way Road?
CFSAN will begin sending letters to companies notifying them when an adverse event report involving one of their products has been received on or after Sept. 16
FDA’s Supplement AER System Nets $1.5 Mil. Under Ag Approps
FDA's dietary supplement adverse event monitoring system will receive $1.5 mil. in funding for FY 2002 under the 1agriculture appropriations conference report adopted by both the House and Senate
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC